rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-3-7
|
pubmed:abstractText |
The prognosis for patients with malignant astrocytoma or brain metastases is often fatal despite intensive therapy. Therefore we wished to elucidate whether the quality of life (QoL) is a determinant of overall survival (OAS).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0378-584X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2003 S. Karger GmbH, Freiburg
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
38-43
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12624516-Adult,
pubmed-meshheading:12624516-Aged,
pubmed-meshheading:12624516-Aged, 80 and over,
pubmed-meshheading:12624516-Astrocytoma,
pubmed-meshheading:12624516-Brain Neoplasms,
pubmed-meshheading:12624516-Cranial Irradiation,
pubmed-meshheading:12624516-Female,
pubmed-meshheading:12624516-Follow-Up Studies,
pubmed-meshheading:12624516-Glioblastoma,
pubmed-meshheading:12624516-Humans,
pubmed-meshheading:12624516-Male,
pubmed-meshheading:12624516-Marital Status,
pubmed-meshheading:12624516-Middle Aged,
pubmed-meshheading:12624516-Outcome Assessment (Health Care),
pubmed-meshheading:12624516-Prognosis,
pubmed-meshheading:12624516-Quality of Life,
pubmed-meshheading:12624516-Radiotherapy, Adjuvant,
pubmed-meshheading:12624516-Regression Analysis,
pubmed-meshheading:12624516-Risk Assessment,
pubmed-meshheading:12624516-Survival Rate
|
pubmed:year |
2003
|
pubmed:articleTitle |
Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy.
|
pubmed:affiliation |
Department of Radiotherapy and Radiooncology, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany. susanne.sehlen@helios.med.uni-muenchen.de
|
pubmed:publicationType |
Journal Article
|